During the past decade, Southern Highlands Cancer Centre conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 2 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 2 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Southern Highlands Cancer Centre" #1 sponsor was "Gilead Sciences" with 3 trials, followed by "Alliance Foundation Trials, LLC." with 1 trials sponsored, "Canadian Cancer Trials Group" with 1 trials sponsored, "ETOP IBCSG Partners Foundation" with 1 trials sponsored and "Molecular Templates, Inc." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Southern Highlands Cancer Centre" #1 collaborator was "Breast International Group" with 2 trials as a collaborator, "Austrian Breast & Colorectal Cancer Study Group" with 1 trials as a collaborator, "Hoffmann-La Roche" with 1 trials as a collaborator, "Merck Sharp & Dohme LLC" with 1 trials as a collaborator and "NSABP Foundation Inc" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Southern Highlands Cancer Centre" are "Breast Cancer" (3 trials), "HER2-positive Solid Cancers" (1 trials), "Metastatic Solid Tumor" (1 trials), "Non-Small Cell Lung Cancer" (1 trials) and "Non-muscle Invasive Bladder Cancer" (1 trials). Many other conditions were trialed in "Southern Highlands Cancer Centre" in a lesser frequency.

Most popular intervention types in "Southern Highlands Cancer Centre" are "Drug" (8 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Sacituzumab Govitecan-hziy (SG)" (2 trials), "Bacillus Calmette-Guerin" (1 trials), "Carboplatin" (1 trials), "Cisplatin" (1 trials) and "Docetaxel" (1 trials). Other intervention names were less common.

The vast majority of trials in "Southern Highlands Cancer Centre" are 7 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Southern Highlands Cancer Centre". undefined are not yet recruiting, 5 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Southern Highlands Cancer Centre, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Southern Highlands Cancer Centre, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".